Rat Coagulation Factor VIII ELISA Kit

Name: Rat Coagulation Factor VIII ELISA Kit
SKU: DEIA-BJ2114
Rating: 5 (1 reviews)

Regulatory status: For research use only, not for use in diagnostic procedures.

COA

SDS

Datasheet

Summary

Sample

Serum, plasma, cell culture supernatants, body fluid and tissue homogenate

Species Reactivity

Rat

Detection Method

Competitive ELISA

Intended Use

Rat Coagulation Factor VIII ELISA Kit is a 1.5 hour solid-phase ELISA designed for the quantitative determination of the Coagulation Factor VIII. This ELISA kit is for research use only, not for therapeutic or diagnostic applications.

Contents of Kit

1. MICROTITER PLATE: 96 wells
2. ENZYME CONJUGATE: 6.0 mL or 10 ml
3. STANDARD A-F: 1 vial each
4. SUBSTRATE A: 6 mL
5. SUBSTRATE B: 6 mL
6. STOP SOLUTION: 6 mL
7. WASH SOLUTION (100 x): 10 mL
8. BALANCE SOLUTION: 3 mL

Storage

All components of this kit are stable at 2-8°C until the kit's expiration date.

Detection Range

5-100 ng/mL

Sensitivity

1.0 ng/mL

Citations

Have you cited DEIA-BJ2114 in a publication? Let us know and earn a reward for your research.

Documents

pdf COA

pdf SDS

pdf Datasheet

QA & Reviews

Customer Reviews

References

Mutation detection and inhibitor risk in Iranian patients with Hemophilia A: Six novel mutations

CLINICAL CASE REPORTS

Authors: Nasirnejad Sola, Farzaneh; Morovvati, Saeid; Sabetghadam Moghadam, Mitra; Entezari, Malihe

Abstract

This investigation facilitates a better understanding of inhibitor development, the critical treatment morbidity in HA patients. Furthermore, six novel mutations are reported, which would expand the mutation spectrum of the F8 gene.

eQTL analysis from co-localization of 2739 GWAS loci detects associated genes across 14 human cancers

JOURNAL OF THEORETICAL BIOLOGY

Authors: Li, Weidong; Zhou, Qingniao; Gao, Yong; Jiang, Yonghua; Huang, Yuanjie; Mo, Zengnan; Zou, Yiming; Hu, Yanling

Abstract

Genetic variants can predict other "linked" diseases because alterations in one or more genes in vivo may affect relevant phenotype properties. Our study systematically explored the pan-cancer common gene and cancer type-specific genes based on GWAS loci and TCGA data of multiple cancers. It was found that there were 17 SNPs were significantly associated with the expression of 18 genes. Associations between the 18 cis-regulatory genes and the pathologic stage of each cancer showed that MYL2 and PTGFR in HNSC, 4 genes (F8, SATB2, G6PD and UGT1A6) in KIRP, 3 genes (CHMP4C, MAP3K1 and MECP2) in LUAD were all strongly associated with cancer stage levels. Additionally, the survival association analysis showed that SATB2 was correlated with HNSC survival, and MPP1 was strongly associated with the survival of SARC. This study will shed light on the biological pathways involved in cancer-genetic associations, and has the potential to be applied to the predictions of the risk of cancers developing in healthy individuals. (C) 2018 Elsevier Ltd. All rights reserved.